UPDATE 2-Esperion says cholesterol drug gets U.S. approval; eyes $10 per pill pricing
February 21, 2020 at 17:51 PM EST
Esperion Therapeutics Inc said on Friday that U.S. health regulators approved its cholesterol-lowering drug, making it the first non-statin treatment to be cleared for sale in the country in nearly 20 years.
